Latest leiomyosarcoma Stories
In a study published in The Oncologist on March 12, 2015, researchers describe the development of a new model that predicts the risk of unexpected uterine sarcoma in women undergoing minimally
Morcellator lawsuits filed on behalf of women who allegedly experienced the spread of uterine sarcoma and other malignancies have been mounting in U.S.
MADRID, February 3, 2015 /PRNewswire/ -- PharmaMar announces that the U.S.
RARITAN, N.J., Feb. 3, 2015 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) announced today that the U.S.
The publication of this latest power morcellator study follows warnings from U.S.
The Firm is evaluating power morcellator lawsuits on behalf of women who are also alleged to have experienced the spread of gynecological cancers due to uterine morcellation. New
Agency Asks Power Morcellator Manufacturers to Add Boxed Warnings to Their Products Regarding Potential to Spread Undiagnosed Uterine Cancers New York NY (PRWEB)
The FDA's new morcelltor cancer warning comes amid growing concerns that uterine morcellation may have caused numerous women to experience the spread of uterine sarcoma, leiomyosarcoma and
Additionally, Trabectedin Expanded Access Program Now Allows Entry of Eligible Patients with Previously Treated Advanced Soft Tissue Sarcoma, Including those with Liposarcoma and Leiomyosarcoma
The Firm is evaluating potential morcellator lawsuits on behalf of woman who allegedly experienced the spread of gynecological cancers, including uterine sarcoma and leiomyosarcoma, following
- Emitting flashes of light; glittering.